摘要
通过对11例单药利妥昔单抗(美罗华)或利妥昔单抗联合硼替佐米(万珂)治疗复发难治性滤泡性淋巴瘤(FL)患者的观察,探讨两种治疗方法的护理观察要点及措施。经给药前有效的护理评估及针对可能出现不良反应(中性粒细胞及血小板减少、疲乏、周围神经病变、胃肠道反应等)进行预防性健康指导,密切监测给药进程,对症护理,药物毒性及不良反应可有效控制,且患者耐受良好。
11 patients with follicular lymphoma who treated by single Rituximab or Rituximab combined with Bortezomib were observed in order to explore nursing points of the two drug therapy. By taking a series of measures： effective nursing assessment before therapy, healthy guidance in side effects （granulocytopenia, thrombocytopenia, fatigue, peripheral neuropathy, gastrointestinal）, close survey the whole process of administration and symptomatic nursing, we can effectively control toxicity and side effects of medicines, and patients can tolerate well.
出处
《天津护理》
2011年第5期268-270,共3页
Tianjin Journal of Nursing
